ask="8.87"
ask_size="100"
average_daily_volume="1033610"
bid="8.74"
bid_size="1400"
book_value="2.50"
change="+0.40"
change_from_200_day_moving_average="1.16"
change_from_50_day_moving_average="0.88"
change_from_52_week_high="-5.76"
change_From_52_week_low="4.70"
change_in_percent="+4.80%"
close="8.74"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.72"
ebitda="-40.30M"
eps_estimate_current_year="-1.74"
eps_estimate_next_quarter="-0.44"
eps_estimate_next_year="-2.27"
ex_dividend_date="N/A"
float_shares="19662000"
high="8.87"
high_52_weeks="14.50"
last_trade_date="3/1/2017"
last_trade_price="8.74"
last_trade_size="51423"
last_trade_time="4:00pm"
low="8.15"
low_52_weeks="4.04"
market_capitalization="217.44M"
moving_average_200_day="7.58"
moving_average_50_day="7.86"
name="Ocular Therapeutix
Inc."
notes="N/A"
one_year_target_price="29.50"
open="8.46"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+15.31%"
percent_change_from_50_day_moving_average="+11.16%"
percent_change_from_52_week_high="-39.72%"
percent_change_from_52_week_low="+116.34%"
previous_close="8.34"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.33"
price_per_sales="114.51"
revenue="1.81M"
shares_outstanding="24879000"
short_ratio="5.23"
stock_exchange="NGM"
symbol="OCUL"
volume="970048"
weeks_range_52="4.04 - 14.50"
